Zevra Therapeutics, Inc. (ZVRA)

Import this data to Google Sheets with:

=jivedata("ZVRA","financials")

Full statements spill as a table. For one cell: =jivedata("ZVRA","Revenue") or =jivedata("ZVRA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Zevra Therapeutics, Inc.

ZVRA • CIK 0001434647

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Including Assessed Tax	$27,461	$23,612	$106,470	$136,071
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization	—	$7,417	$16,482	$6,180
Amortization of Intangible Assets	$800	$6,235	$3,862	$1,263
Impairment of Intangible Assets, Finite-lived	—	$0	$58,710	$43,300
Operating Income (Loss)	$-49,604	$-87,003	$-62,943	$82,381
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-46,049	$-90,140	$86,678	$69,288
Income Tax Expense (Benefit)	$0	$15,371	$3,449	$11,025
Net Income (Loss) Attributable to Parent	$-46,049	$-105,511	$83,229	$58,263
Research and Development Expense (Excluding Acquired in Process Cost)	$39,806	$42,095	$12,743	$14,930
Selling, General and Administrative Expense	$34,314	$54,868	$77,616	$74,631
Costs and Expenses	$77,065	$96,963	$90,359	$89,561
Gain (Loss) on Disposition of Intangible Assets	—	—	$148,325	$0
InterestExpenseNonoperating	—	$7,351	$7,977	$5,710
Nonoperating Income (Expense)	$3,555	$-3,137	$149,621	$-13,093
Weighted Average Number of Shares Outstanding, Basic	35,452,460	46,251,239	55,311,308	59,654,242
Weighted Average Number of Shares Outstanding, Diluted	—	—	57,262,715	61,985,897
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	7,332,614	6,631,549	1,571,228	1,522,679
Participating Securities, Distributed and Undistributed Earnings (Loss), Basic	—	—	$5,644	$1,016
Net Income (Loss) Available to Common Stockholders, Basic	$-46,049	$-105,511	$77,585	$57,247
Preferred Stock Dividends, Income Statement Impact	—	—	$0	$0
Undistributed Earnings (Loss) Available to Common Shareholders, Basic	—	—	$77,585	$57,247
Weighted Average Number Diluted Shares Outstanding Adjustment	—	—	1,952,000	2,333,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$43,049	$33,785	$62,406	$145,321
Debt Securities, Available-for-sale, Current	$24,688	$35,711	$128,605	$76,249
Debt Securities, Available-for-sale, Noncurrent	—	$6,010	$47,879	$38,609
Accounts and Other Receivables, Net, Current	$17,377	$10,509	$23,258	$22,489
Inventory, Noncurrent	$9,841	$10,999	$879	$0
Prepaid Expense and Other Assets, Current	$1,824	$4,052	$6,998	$4,794
Property, Plant and Equipment, Net	$736	$356	$489	$641
Inventory, Net	$9,841	$1,970	$1,740	$2,449
Operating Lease, Right-of-Use Asset	$790	$657	$1,212	$1,667
Assets, Current	$86,938	$86,027	$223,007	$251,302
Goodwill	$4,701	$4,701	$4,701	$4,701
Intangible Assets, Net (Excluding Goodwill)	$69,227	$68,993	$6,421	$5,789
Other Assets, Noncurrent	$94	$384	$143	$3
Assets	$172,327	$178,127	$284,731	$302,712
Long-term Debt, Excluding Current Maturities	—	$59,504	$61,928	$0
Accrued Income Taxes, Noncurrent	—	$14,431	$7,029	$7,206
Operating Lease, Liability, Noncurrent	$456	$372	$859	$870
Other Liabilities, Noncurrent	$7,458	$4,630	$1,713	$2,087
Liabilities	$110,463	$138,461	$130,074	$85,060
Accounts Payable and Accrued Liabilities, Current	$28,403	$25,456	$11,598	$13,962
Operating Lease, Liability, Current	$543	$420	$419	$626
Accrued Income Taxes, Current	—	—	$13,710	$20,844
Other Liabilities, Current	$2,524	$3,200	$1,362	$1,423
Liabilities, Current	$73,720	$34,065	$39,277	$48,632
Preferred Stock, Value, Issued	—	—	$0	$0
Common Stock, Value, Outstanding	—	—	$6	$6
Additional Paid in Capital, Common Stock	$472,664	$555,302	$588,458	$606,264
Treasury Stock, Value	$10,983	$10,983	$10,983	$10,983
Retained Earnings (Accumulated Deficit)	$-399,778	$-505,289	$-422,060	$-375,418
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-43	$631	$-764	$-2,217
Stockholders' Equity Attributable to Parent	$61,864	$39,666	$154,657	$217,652
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	—	0	0	0
Common Stock, Shares Authorized	250,000,000	250,000,000	250,000,000	250,000,000
Common Stock, Shares, Issued	43,110,360	55,246,401	58,338,319	60,917,598
Common Stock, Shares, Outstanding	41,534,668	53,670,709	56,854,781	59,341,906
Operating Lease, Liability	$999	$792	$1,278	$1,496

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-46,049	$-105,511	$83,229	$58,263
Net Cash Provided by (Used in) Operating Activities	$-33,535	$-69,665	$-1,598	$33,399
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$44	$454	$28	$-367
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-22,417	$-9,264	$28,621	$97,609
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$43,049	$33,785	$62,406	$120,661
Share-based Payment Arrangement, Noncash Expense	$5,954	$14,906	$12,634	$13,129
Payments to Acquire Property, Plant, and Equipment	$296	$0	$835	$775
Impairment of Intangible Assets, Finite-lived	—	$0	$58,710	$43,300
Proceeds from Sale of Property, Plant, and Equipment	—	—	$448	$490
Inventory Write-down	—	$5,746	$11,681	$485
Payments to Acquire Other Investments	—	$41,161	$309,986	$233,110
Proceeds from Sale, Maturity and Collection of Investments	$59,121	$25,000	$178,500	$291,222
Depreciation, Depletion and Amortization	$1,006	$6,389	$4,054	$1,486
Paid-in-Kind Interest	—	$2,089	$2,649	$2,649
Payments to Acquire Intangible Assets	—	$6,000	$0	$0
Operating Lease, Right-of-Use Asset, Amortization Expense	—	—	$602	$842
Net Cash Provided by (Used in) Investing Activities	$-17,390	$-22,161	$18,127	$106,720
Accretion (Amortization) of Discounts and Premiums, Investments	—	$890	$3,128	$3,287
Foreign Currency Transaction Gain (Loss), before Tax	$198	$-219	$-1,548	$392
Gain (Loss) on Disposition of Intangible Assets	—	—	$148,325	$0
Increase (Decrease) in Accounts and Other Receivables	$9,078	$-6,868	$11,977	$3,858
Proceeds from Issuance of Debt	$42,431	$58,990	$0	$0
Increase (Decrease) in Prepaid Expense and Other Assets	$-152	$2,228	$2,943	$445
Repayments of Debt	$17,531	$42,700	$0	$60,092
Increase (Decrease) in Inventories	$-206	$8,874	$1,305	$1,044
Increase (Decrease) in Other Noncurrent Assets	$5	$0	$-451	$-496
Proceeds from Repayment of Loans by Employee Stock Ownership Plans	—	—	$615	$636
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$11,130	$-3,598	$-15,587	$-2,527
Proceeds from Issuance of Common Stock	$6,106	$64,516	$0	$0
Proceeds from Stock Options Exercised	—	$1,684	$3,182	$3,182
IncreaseDecreaseInOperatingLeaseLiability	$-439	$-626	$-675	$-1,655
Proceeds from Warrant Exercises	—	—	$8,639	$17,810
Increase (Decrease) in Other Noncurrent Liabilities	$360	$835	$-1,159	$-2,343
Payments of Financing Costs	—	$2,091	$0	$0
Net Cash Provided by (Used in) Financing Activities	$28,464	$82,108	$12,064	$-42,143
Interest Paid, Excluding Capitalized Interest, Operating Activities	$456	$5,262	$5,329	$4,073
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability	$0	$0	$1,115	$460

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("ZVRA","financials")

Full statements spill as a table. For one cell: =jivedata("ZVRA","Revenue") or =jivedata("ZVRA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.